Publications by authors named "B A Rockwell"

Article Synopsis
  • - A study found that a low-dose regimen of decitabine and venetoclax was both safe and effective for treating myeloid cancers in an older, diverse group with minimal need to reduce or pause treatment.
  • - Patients with acute myeloid leukemia who had a TP53 mutation had a median overall survival of 16.1 months, while those without the mutation had an overall survival of 11.3 months.
  • - This clinical trial is officially registered at www.clinicaltrials.gov under the identifier #NCT05184842.
View Article and Find Full Text PDF

Purpose: To explore the potential of testosterone therapy in managing cytopenias in myelodysplastic neoplasm and investigate the link between hypogonadism and hematologic malignancies.

Methods: A case of a patient with intermediate-risk myelodysplastic neoplasm and hypogonadism treated with testosterone replacement therapy is presented. Testosterone, prostate specific antigen, and erythropoietin levels were checked prior to therapy initiation and 3 months after.

View Article and Find Full Text PDF

Objectives: This study investigated anthropometric changes of national law enforcement officers (LEOs) in 46 years, compared the differences between LEO data and civilian anthropometry, and identified the magnitude of differences in dimensions measured with gear versus semi-nude measurements.

Background: The best available 46-year-old anthropometric dataset of LEOs has largely become outdated due to demographic changes. Additionally, anthropometric data of female LEOs and LEO measurements with gear are lacking.

View Article and Find Full Text PDF

Patients with cancer have been identified in several studies to be at high risk of developing severe COVID-19; however, rates of SARS-CoV-2 IgG seroconversion and its association with cancer types and anti-cancer therapy remain obscure. We conducted a retrospective cohort study in patients with cancer that underwent SARS-CoV-2 IgG testing. Two hundred and sixty-one patients with a cancer diagnosis underwent SARS-CoV-2 IgG testing and demonstrated a high rate of seroconversion (92%).

View Article and Find Full Text PDF